You can find the annual or quarterly income statement of Alamar Biosciences Ord Shs here for insights into the performance and operational efficiency of Alamar Biosciences Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Total revenue
--26.04M
Revenue
--26.04M
Cost of revenue
--11.58M
Operating expenses
--38.38M
R&D expenses
--13.02M
Depreciation, depletion, and amortization
--1.17M
Operating profit
---12.35M
Net non-operating interest income (expenses)
Non-operating interest income
--539.00K
Non-operating interest expense
--223.00K
Special income (expenses)
---8.59M
Other non-operating income (expenses)
---236.00K
Income before tax
---20.86M
Income tax
--464.00K
Income after tax
---21.32M
Net income from continuous operations
---21.32M
Net income attributable to controlling interests
---21.32M
Net income attributable to common shareholders
---21.32M
Basic earnings per share
---0.32
Diluted earnings per share
---0.32
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.